Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hiroaki Okida"'
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44314 (2012)
MicroRNA (miRNA) precursor hairpins have a unique secondary structure, nucleotide length, and nucleotide content that are in most cases evolutionarily conserved. The aim of this study was to utilize position-specific features of miRNA hairpins to imp
Externí odkaz:
https://doaj.org/article/7575bc012ed846ff9746ddf00b6d309c
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Takashi Kagari, Kenji Hirotani, Yuuri Hashimoto, Masanori Funabashi, Ryoto Yoshimoto, Maki Kobayashi, Hiroaki Okida, Eri Otsuka, Hiroki Goto, Asuka Tsuya, Yasutaka Chiba, Kazuko Sakai, Hidetoshi Hayashi, Kaoru Tanaka, Hisato Kawakami, Koji Haratani, Osamu Maenishi, Junko Tanizaki, Kimio Yonesaka
Supplementary Table from HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::193a3c11e4e3e804b1cd4a8031602911
https://doi.org/10.1158/1078-0432.22487915.v1
https://doi.org/10.1158/1078-0432.22487915.v1
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Takashi Kagari, Kenji Hirotani, Yuuri Hashimoto, Masanori Funabashi, Ryoto Yoshimoto, Maki Kobayashi, Hiroaki Okida, Eri Otsuka, Hiroki Goto, Asuka Tsuya, Yasutaka Chiba, Kazuko Sakai, Hidetoshi Hayashi, Kaoru Tanaka, Hisato Kawakami, Koji Haratani, Osamu Maenishi, Junko Tanizaki, Kimio Yonesaka
Supplementary Figure from HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::318557b3f697f81f5990207a8834d461
https://doi.org/10.1158/1078-0432.22487939.v1
https://doi.org/10.1158/1078-0432.22487939.v1
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Takashi Kagari, Kenji Hirotani, Yuuri Hashimoto, Masanori Funabashi, Ryoto Yoshimoto, Maki Kobayashi, Hiroaki Okida, Eri Otsuka, Hiroki Goto, Asuka Tsuya, Yasutaka Chiba, Kazuko Sakai, Hidetoshi Hayashi, Kaoru Tanaka, Hisato Kawakami, Koji Haratani, Osamu Maenishi, Junko Tanizaki, Kimio Yonesaka
Purpose:EGFR-tyrosine kinase inhibitor (TKI) is a standard first-line therapy for activated EGFR-mutated non–small cell lung cancer (NSCLC). Treatment options for patients with acquired EGFR-TKI resistance are limited. HER3 mediates EGFR-TKI resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c6ed051d8ae4eb6ca20cb9d295f077e
https://doi.org/10.1158/1078-0432.c.6532610.v1
https://doi.org/10.1158/1078-0432.c.6532610.v1
Autor:
Kimio Yonesaka, Junko Tanizaki, Osamu Maenishi, Koji Haratani, Hisato Kawakami, Kaoru Tanaka, Hidetoshi Hayashi, Kazuko Sakai, Yasutaka Chiba, Asuka Tsuya, Hiroki Goto, Eri Otsuka, Hiroaki Okida, Maki Kobayashi, Ryoto Yoshimoto, Masanori Funabashi, Yuuri Hashimoto, Kenji Hirotani, Takashi Kagari, Kazuto Nishio, Kazuhiko Nakagawa
Publikováno v:
Clinical Cancer Research. 28:390-403
Purpose: EGFR-tyrosine kinase inhibitor (TKI) is a standard first-line therapy for activated EGFR-mutated non–small cell lung cancer (NSCLC). Treatment options for patients with acquired EGFR-TKI resistance are limited. HER3 mediates EGFR-TKI resis
Autor:
Kimio Yonesaka, Junko Tanizaki, Osamu Maenishi, Koji Haratani, Hisato Kawakami, Kaoru Tanaka, Hidetoshi Hayashi, Kazuko Sakai, Yasutaka Chiba, Hiroki Goto, Eri Otsuka, Hiroaki Okida, Maki Kobayashi, Ryoto Yoshimoto, Masanori Funabashi, Yuuri Hashimoto, Kenji Hirotani, Takashi Kagari, Kazuto Nishio, Kazuhiko Nakagawa
Publikováno v:
Journal of Clinical Oncology. 40:e21175-e21175
e21175 Background: Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is a standard first-line therapy for activated EGFR-mutated non-small-cell lung cancer (NSCLC). Treatment options for patients with acquired EGFR-TKI resistance
Publikováno v:
Nucleic Acids Research
More than 40% of the human genome is generated by retrotransposition, a series of in vivo processes involving reverse transcription of RNA molecules and integration of the transcripts into the genomic sequence. The mechanism of retrotransposition, ho
Autor:
Takashi Komori, Kouichirou Yamada, Kiyoshi Asai, Emi Hattori, Yukiteru Ono, Hiroaki Okida, Toutai Mituyama, Goro Terai, Aya Yoshizawa
Publikováno v:
Nucleic Acids Research
We developed a pair of databases that support two important tasks: annotation of anonymous RNA transcripts and discovery of novel non-coding RNAs. The database combo is called the Functional RNA Database and consists of two databases: a rewrite of th
Autor:
Hiroaki Okida, Taishin Kin, Kiyoshi Asai, Takashi Komori, Kouichirou Yamada, Yuki Kimura, Yukiteru Ono, Yasuhiko Yoshinari, Aya Kojima, Goro Terai
Publikováno v:
Nucleic Acids Research
There are abundance of transcripts that code for no particular protein and that remain functionally uncharacterized. Some of these transcripts may have novel functions while others might be junk transcripts. Unfortunately, the experimental validation
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 9, p e44314 (2012)
PLoS ONE, Vol 7, Iss 9, p e44314 (2012)
MicroRNA (miRNA) precursor hairpins have a unique secondary structure, nucleotide length, and nucleotide content that are in most cases evolutionarily conserved. The aim of this study was to utilize position-specific features of miRNA hairpins to imp